Mobile teleconsulting can evaluate stroke patients
By Will Boggs, MD
NEW YORK (Reuters Health) - Mobile teleconsulting is a feasible way to evaluate remotely located patients who have just had a stroke, according to a report in the current issue of the journal Stroke. Although researchers found that hospital-based, land-line systems still provide better quality communication.
In a study involving 2 stroke centers and 14 local hospitals in Germany, investigators analyzed telephone consultations performed at fixed telemedicine workstations using high-speed Internet connections and laptops that could be taken to remote sites.
Specifically, the researchers compared the technical parameters, acceptability, and impact on immediate clinical decisions of consultations performed with the mobile vs land-line devices.
The teleconsultants reported that the process took longer when the laptops were used, despite almost identical download time measurements. They also rated the video and audio quality to be better with the hospital-based system.
Although the technical quality of the mobile communication was rated worse on both sides, “this did not affect the ability to make remote decisions like initiating thrombolysis,” a “clot-busting” drug treatment for stroke, and the mobile system was technically stable, the authors report.
“During times of low teleconsultation frequency, this service can be provided from home or from elsewhere,” Dr. Heinrich J. Audebert from Charite Universitatsmedizin in Berlin told Reuters Health. “Currently, the technical quality of mobile teleconsultation is not equivalent to landline connections.”
He and his colleagues point out while mobile devices are feasible in low-frequency circumstances, a hospital-based device would ensure optimal quality when teleconsultation frequency is high.
“Telemedicine in stroke care is only an instrument to make stroke expertise more available,” Audebert stressed. It does not replace on-site, high-quality stroke treatment. “Therefore, a lot of specialized infrastructure, training, and quality monitoring are needed in telemedicine networks.”
“We are currently investigating the use of telemedicine in pre-hospital stroke care,” Audebert added. “We use telemedicine equipment in ambulance cars and patients are examined via videoconferencing before they are admitted to the hospital.”
SOURCE: Stroke, December 2008.
--------------------------------------------------------------------------------------------Related Posts:
LONDON (Reuters) - Doctors baffled by an unexplained rash on people’s ears or cheeks should be on alert for a skin allergy caused by too much mobile phone use, the British Association of Dermatologists said on Thursday. Citing published studies, the group said a red or itchy rash, known as “mobile phone dermatitis,” affects people who
Full Post: Doctors warn of rash from mobile phone use
--------------------------------------------------------------------------------------------
By Andrew Stern CHICAGO (Reuters) - The brains of autistic children react to sounds a fraction of a second slower than those of normal children, which may help explain the communication problems associated with autism, researchers said on Monday. “What this does is it provides strong supporting evidence for the emerging theory that autism is a problem
Full Post: Brains of autistic slower to react to sounds: study
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - An organ allocation policy that puts the sickest patients first in line to receive available donor livers for transplantation has created some unintended consequences for those patients low on the organ wait list, research suggests. Since the new donor organ allocation system was implemented in early 2002, there has been a
Full Post: Policy has changed how organs are allocated
--------------------------------------------------------------------------------------------
By Julie Steenhuysen CHICAGO (Reuters) - Implantable heart defibrillators — which have been found to save lives in younger patients — appear to have the same benefit for people over 70, U.S. researchers said on Tuesday. The study suggests the devices, known as implantable cardioverter defibrillators or ICDs, should be offered to people in their 70s despite
Full Post: Implantable defibrillators save older patients too
--------------------------------------------------------------------------------------------
BRUSSELS (Reuters) - Belgian health products distributor Omega Pharma will launch a chip it claims can counter potentially damaging radiation from mobile phones and has high hopes for its sales. The company, which sells non-prescription products such as wart treatments, pregnancy tests and sun tan lotions to pharmacists, unveiled the E-waves phone chip on Tuesday, a
Full Post: Mobile phone chip to counter radiation unveiled